Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in
  • Log out

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
  • Log out
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

December 01, 1999; 53 (9) Brief Communications

Vasogenic edema on MELAS: A serial study with diffusion-weighted MR imaging

M. Yoneda, M. Maeda, H. Kimura, A. Fujii, K. Katayama, M. Kuriyama
First published December 1, 1999, DOI: https://doi.org/10.1212/WNL.53.9.2182
M. Yoneda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Maeda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. Kimura
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Fujii
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K. Katayama
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Kuriyama
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Vasogenic edema on MELAS: A serial study with diffusion-weighted MR imaging
M. Yoneda, M. Maeda, H. Kimura, A. Fujii, K. Katayama, M. Kuriyama
Neurology Dec 1999, 53 (9) 2182; DOI: 10.1212/WNL.53.9.2182

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
206

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Abstract

Article abstract The authors performed a serial study of a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like syndrome (MELAS) who presented with diffusion-weighted MRI (DWI). DWI demonstrated a higher apparent diffusion coefficient in the lesion than in the control region during the acute stage of stroke. Vasogenic edema is present in stroke-like episodes in MELAS.

The pathogenic mechanism for the stroke-like episodes in patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) is unclear. Electron and light microscopic examinations of brain autopsy tissue from a MELAS patient revealed “mitochondrial angiopathy” characterized by increased numbers of enlarged mitochondria in the endothelial cells of intracerebral small vessels.1 From a pathologic study of brain autopsy tissue of a MELAS patient, it has been shown that most stroke regions extend over vascular territories.2 Cerebral angiography failed to demonstrate any embolic or stenotic lesion,3 suggesting that the underlying pathogenic mechanism for the stroke-like episodes is different than ischemic infarction. MR diffusion-weighted imaging (DWI) can detect proton mobility in brain tissue and can discriminate between vasogenic edema and cytotoxic edema in the stroke region of acute ischemic infarction.4 We performed serial DWI in the stroke region of a patient with MELAS.

Case report.

A 10-year-old boy with a history of recurrent strokes, migraine headaches, vomiting, and visual disturbance since 9 years of age was admitted to Fukui Pref. Saiseikai Hospital in September 1998. After leukocyte DNA examination revealed an A-to-G transition mutation at the nucleotide position 3243 in the tRNALeu(UUR) gene of mitochondrial DNA, he was diagnosed with MELAS. After IV administration of dexamethasone (12 mg/day), migraine headache and visual disturbance markedly improved. Between strokes, he presented with mild myoclonic jerks affecting the arms and legs and mild truncal ataxia.

In December 1998, at 10 years of age, he was admitted to Fukui Medical University Hospital for a follow-up examination. The light microscopic study of the skeletal muscle biopsy specimen revealed ragged-red fibers and strongly SDH-stained vessels, both of which were compatible with the pathologic findings in MELAS. We performed a MRI study including DWI. In January 1999, 5 days after discharge from the hospital, he experienced a migraine headache with scintillating scotoma in the left visual field again and was immediately readmitted to the hospital (day 1). Neurologic examination showed mild truncal ataxia, left homonymous hemianopsia, and myoclonic jerks affecting the arms and legs. Brain MRI (T2-weighted image [T2WI]) showed a recently formed focal high-intensity signal in the right occipital lobe (figure 1B). An electroencephalogram showed slow background activity mixed with high-amplitude and slow-wave bursts. The total protein in cerebrospinal fluid was normal without pleocytosis. Lactate in cerebrospinal fluid was markedly increased (41.4 mg/dL; normal control, 9 to 25 mg/dL). He had been treated with IM administration of dexamethasone (4 mg/day) for a week, and migraine and hemianopsia markedly improved. Two days after the administration of dexamethasone had ceased (day 8), he experienced a mild headache and scotoma on day 9 and began taking medication again on day 10. His symptoms disappeared in a few days.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 1. The T2-weighted image (A–C) and apparent diffusion coefficient (ADC) maps (D–F) of the stroke region at several time points in a MELAS patient. (A and D) The period in which the patient had no stroke (day 0). (B and E) Two days after the stroke onset. (C and F) Twenty-four days after the stroke onset in which his visual disturbance disappeared. Arrows indicate the stroke region. Notice that the intensity of ADC in the stroke region is increased in the acute stage of stroke.

MRI studies.

Brain MRI was performed on hospital days 3, 10, 17, and 25. Brain MRI also was performed 14 days before the stroke onset (day 0). The patient was examined with a GE Signa 1.5-T MR unit by standard spin-echo (SE) sequences for T1-weighted images, fast SE sequences for T2-WI, fast fluid-attenuated inversion-recovery (FLAIR) images, and diffusion-weighted SE images. MR angiography of the circle of Willis and its major branches also was performed. Diffusion imaging was performed using a multislice, single-shot, SE planar sequence. The imaging measurements were TE = 3200 milliseconds, matrix size 250 × 256, fields of view 220 mm, with a 5-mm slice thickness. Diffusion gradients were applied in each of the x, y, and z directions with four b values ranging between 0 and 1000 seconds/minute2. Maps of apparent diffusion coefficient (ADC) were created by signals obtained from images with four b values according to the method previously described.4 Average ADC (ADCav) was calculated as ADCav = 1/3(ADCx + ADCy + ADCz). To quantitate changes in ADCav independent of tissue and gradient orientations, relative ADCav (ipsilateral/contralateral of ADCav) was calculated according to the method previously described.5

MRI findings and ADC maps.

Two days after the onset of the stroke, MRI showed a focus with increased T2 signal in the right occipital lobe (see figure 1B) compared with the signal in the same region in the period without stroke (day 0) (figure 1A). On day 25 (figure 1C), his visual disturbance disappeared. MR angiography of brain vessels on day 3 demonstrated no significant stenosis or spasms in the circle of Willis or its major branches. ADC maps showed increased intensities of ADC in the stroke region on day 3 (figure 1E) compared with those on days 0 (figure 1D) and 25 (figure 1F). As shown in figure 2, the ADCav ratio of the stroke region relative to the contralateral control side (rADC) reached a peak (1.52) on day 3 and gradually decreased on days 10 (1.32) and 17 (1.25); then, on day 25, it reached the level (1.02) equal to before the onset of the stroke (1.08). The level of lactate remained high (34.5 mg/dL) even after the abnormal signals on T2WI and DWI had disappeared.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 2. Plot of the time course of the relative apparent diffusion coefficient (rADC). Notice that the rADC increased 2 days after the stroke onset and decreased gradually for 24 days after onset.

Discussion.

Conventional MRI techniques, such as T2WI or FLAIR, cannot distinguish cytotoxic edema from vasogenic edema in the stroke region. DWI, a recent advance in the MRI technique, can detect proton mobility in brain tissue and determine whether the edema during the acute stage of an ischemic infarction is vasogenic or cytotoxic in origin.4 In general, in acute ischemic infarctions, intracellular diffusion of protons is restricted or reduced, corresponding to low signals on ADC maps.4 We applied this MRI technique in a MELAS patient to investigate whether vasogenic or cytotoxic edema is involved during the acute stage of stroke-like episodes. In this MELAS patient, the ADC maps and rADC ratios of the stroke region, compared with the control side, demonstrated a higher proton mobility, which corresponded to the high signals on ADC maps (see figures 1E and 2⇑). This is contrary to the time course of rADC in acute ischemic infarction. Schlaug et al. demonstrated that a significant reduction of rADC lasts for at least 4 days from stroke onset, and an increasing trend from reduction through pseudonormalization to elevation of rADC occurred on day 7.4 From the duration of rADC in our MELAS patient, high mobility of protons in the stroke region strongly suggests that vasogenic, as opposed to cytotoxic, edema is a predominant feature in the stroke region.

Such a vasogenic edema has been described in “reversible posterior leukoencephalopathy,” which was seen in patients with hypertensive encephalopathy or eclampsia, and vasogenic edema was detected by DWI.6,7 Enhanced lesions have been reported in the stroke regions in MELAS on brain MRI or CT, and a breakdown of the blood–brain barrier has been speculated.8 The high mobility of protons in the stroke region that was detected by DWI in this case strongly supports the idea that there is increased permeability in the blood–brain barrier, presumably based on mitochondrial respiratory failure in the cerebral artery endothelium.

  • Received May 10, 1999.
  • Accepted August 10, 1999.

References

  1. ↵
    Ohama E, Ohara S, Ikuta F, Tanaka K, Nishizawa M, Miyatake T. Mitochondrial angiopathy in cerebral blood vessels of mitochondrial encephalomyopathy. Acta Neuropathol (Berl) 1987;74:226–233.
    OpenUrlCrossRefPubMed
  2. ↵
    Kuriyama M, Umezaki H, Fukuda Y, et al. Mitochondrial encephalomyopathy with lactate–pyruvate elevation and brain infarctions. Neurology 1984;34:72–77.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Abe K, Inui T, Hirono N, Mezaki T, Kobayashi Y, Kameyama M. Fluctuating MR images with mitochondrial encephalopathy, lactic acidosis, stroke-like syndrome (MELAS). Neuroradiology 1990;32:77.
    OpenUrlCrossRefPubMed
  4. ↵
    Schlaug G, Siewert B, Benfield A, Edelman RR, Warach S. Time course of the apparent diffusion coefficient (ADC) abnormality in human stroke. Neurology 1997;49:113–119.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    Ulug AM, Beauchamp N Jr, Bryan RN, van Zijl PCM. Absolute quantitation of diffusion constants in human stroke. Stroke 1997;28:483–490.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Schwartz RB, Mulkern RV, Gudbjartsson H, Jolesz F. Diffusion-weighted MR imaging in hypertensive encephalopathy: clues to pathogenesis. Am J Neuroradiol 1998;19:859–862.
    OpenUrlAbstract
  7. ↵
    Schaefer PW, Buonanno FS, Gonzalez RG, Schwamm LH. Diffusion-weighted imaging discriminates between cytotoxic and vasogenic edema in a patient with eclampsia. Stroke 1997;28:1082–1085.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    Kim IO, Kim JH, Kim WS, Hwang YS, Yeon KM, Han MC. Mitochondrial myopathy-encephalopathy-lactic acidosis-and stroke like episodes (MELAS) syndrome: CT and MR findings in seven children. Am J Radiol 1996;166:641–645.
    OpenUrlPubMed

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Case report.
    • Discussion.
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

SARS-CoV-2 Vaccination Safety in Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and Multifocal Motor Neuropathy

Dr. Jeffrey Allen and Dr. Nicholas Purcell

► Watch

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published

Recommended articles

  • Articles
    Slowly progressive spread of the stroke-like lesions in MELAS
    Takahiro Iizuka, Fumihiko Sakai, Shinichi Kan et al.
    Neurology, November 10, 2003
  • Articles
    MRI abnormalities associated with partial status epilepticus
    M.G. Lansberg, M.W. O’Brien, A.M. Norbash et al.
    Neurology, March 01, 1999
  • Articles
    Posterior leukoencephalopathy without severe hypertension
    Utility of diffusion-weighted MRI
    H. Ay, F. S. Buonanno, P. W. Schaefer et al.
    Neurology, November 01, 1998
  • Articles
    Diffusion-weighted MRI in acute stroke within the first 6 hours
    1.5 or 3.0 Tesla?
    C. Rosso, A. Drier, D. Lacroix et al.
    Neurology, May 12, 2010
Neurology: 100 (13)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise